SCHEMBL7974060

SCHEMBL7974060

Cc1ccc(Cn2cnc3nc(-c4ccccc4F)nc(O)c32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.41
CYP11B1 P15538 2/20 0.41
CYP11B2 P19099 2/20 0.41
LMNA P02545 2/20 0.41
HTT P42858 1/20 0.41
MAPK14 Q16539 1/20 0.40
THRB P10828 1/20 0.39
MET P08581 2/20 0.38
HDAC1 Q13547 3/20 0.38
HDAC6 Q9UBN7 2/20 0.38
HPGD P15428 1/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
NPC1 O15118 1/20 0.35
NFKB1 P19838 1/20 0.35
RAB9A P51151 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CCNA2 P20248 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988184 0.91 MET (0.42) SMN1; SMN2CYP11B1CYP11B2LMNAHTT
SCHEMBL7974646 0.91 MAPK14 (0.47) SMN1; SMN2CYP11B1CYP11B2MAPK14MET
SCHEMBL7974309 0.88 CYP11B1 (0.45) SMN1; SMN2CYP11B1CYP11B2LMNAHTT
SCHEMBL7984199 0.88 NR1H4 (0.44) SMN1; SMN2CYP11B1CYP11B2MAPK14MET
SCHEMBL7984878 0.84 MAPK14 (0.42) SMN1; SMN2LMNAHTTMAPK14MET
SCHEMBL7973917 0.84 LMNA (0.40) LMNAMAPK14METHDAC1HDAC6
SCHEMBL7984717 0.84 SMN1; SMN2 (0.46) SMN1; SMN2CYP11B1CYP11B2LMNAHTT
SCHEMBL7988454 0.83 MAPK14 (0.41) CYP11B1CYP11B2MAPK14METGAA
SCHEMBL7991532 0.83 SMN1; SMN2 (0.43) SMN1; SMN2CYP11B1CYP11B2LMNAHTT
SCHEMBL7985165 0.82 MET (0.47) SMN1; SMN2CYP11B1CYP11B2LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed